Benzocaine

Benzocaine

SCHEMBL18740972

CCOC(=O)c1ccc(N)cc1.COc1cc(C(=O)O)ccc1O

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 1/20 0.74
HTT P42858 1/20 0.66
CYP1A2 P05177 2/20 0.63
LMNA P02545 1/20 0.63
CYP3A4 P08684 1/20 0.63
MAOA P21397 1/20 0.63
KDM4E B2RXH2 1/20 0.59
POLB P06746 1/20 0.59
HDAC6 Q9UBN7 1/20 0.59
CA12 O43570 3/20 0.52
CA1 P00915 3/20 0.52
CA2 P00918 3/20 0.52
CA7 P43166 3/20 0.52
CA9 Q16790 3/20 0.52
CA14 Q9ULX7 3/20 0.52
TSHR P16473 1/20 0.52
RAB9A P51151 3/20 0.51
SLC22A6 Q4U2R8 1/20 0.51
SLC22A8 Q8TCC7 1/20 0.51
MEN1 O00255 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Vanillic Acid SCHEMBL431677 0.92 HSD17B2 (0.88) HSD17B2HTTCYP1A2KDM4EPOLB
SCHEMBL155638 0.86 HSD17B2 (1.00) HSD17B2HTTCYP1A2LMNACYP3A4
Procaine SCHEMBL18741023 0.85 CYP2D6 (0.69) HSD17B2HTTCYP1A2LMNACYP3A4
Alcohol SCHEMBL27898607 0.83 HSD17B2 (0.94) HSD17B2HTTCYP1A2KDM4EPOLB
Benzocaine SCHEMBL8215681 0.83 LMNA (0.86) HTTCYP1A2LMNACYP3A4MAOA
SCHEMBL11884205 0.82 HSD17B2 (0.86) HSD17B2HTTCYP1A2KDM4EPOLB
Vanillic Acid SCHEMBL27955356 0.81 HTT (0.93) HSD17B2HTTCYP1A2LMNAKDM4E
Benzocaine SCHEMBL15200678 0.81 LMNA (0.96) HSD17B2HTTCYP1A2LMNACYP3A4
Vanillic Acid SCHEMBL26179 0.81 HTT (1.00) HSD17B2HTTCYP1A2LMNAKDM4E
Vanillic Acid SCHEMBL9711598 0.81 HTT (1.00) HSD17B2HTTCYP1A2LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180297966-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME INNOVATIVE ANESTHETICS, LLC 2018-10-18 US claimed
WO-2017066787-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME LEBEDYEVA IRYNA O (US) 2017-04-20 WO claimed
US-20180297966-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME INNOVATIVE ANESTHETICS, LLC 2018-10-18 US disclosed
WO-2017066787-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME LEBEDYEVA IRYNA O (US) 2017-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180297966-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME TRPA1, TRPV1, AQP1 HSD17B2 273/4885HTT 437/4885CYP1A2 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.